Estradiol (HRT)
Brand names: Estradot (patch), Oestrogel (gel), Elleste Solo (tablet), Evorel (patch)
Estradiol (HRT) is natural oestrogen used as hormone replacement therapy to relieve menopausal symptoms such as vasomotor flushes and urogenital atrophy.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Activates oestrogen receptors to replace declining endogenous oestrogen, easing vasomotor and urogenital symptoms and supporting bone density.
Prescribing in practice
- Unopposed systemic oestrogen must be avoided in women with a uterus; pair it with a progestogen to protect the endometrium.
- Choose the transdermal route preferentially where venous thromboembolism risk is a concern, as it avoids the first-pass increase in clotting risk.
- Individualise the decision around breast cancer, stroke and thrombosis risk and review at least annually.
Monitoring
Reassess symptoms, blood pressure and treatment benefit-risk at least annually, and investigate unscheduled bleeding promptly.
Counselling the patient
- Seek advice for unexpected bleeding, breast changes, or symptoms suggesting a clot.
- Continue breast and cervical screening when invited.
- Take any accompanying progestogen exactly as prescribed if you still have a womb.
Evidence & guidelines
NICE menopause guidance supports hormone replacement therapy for menopausal symptom relief with individualised risk assessment.
Reference: WHI trial (Rossouw et al. JAMA 2002); Million Women Study (Lancet 2003); MHRA HRT Update 2023; NICE NG23 (Menopause 2015, updated 2024); SPC Estradot; Collaborative MNSG Lancet 2019; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- DAPT Score for Dual Antiplatelet Therapy Duration · Antiplatelet Therapy
- ACC/AHA Pooled Cohort Equations (ASCVD Risk) · Cardiovascular Risk
- DAPT Decision Tool (Ticagrelor vs Clopidogrel) · Antiplatelet Therapy
- Weight-Based Levothyroxine Dose Calculator · Thyroid
- Travis Criteria for Severe Ulcerative Colitis · Inflammatory Bowel Disease
- Milan Criteria vs UCSF Criteria for Liver Transplantation in HCC · Liver Transplantation